MIC
MRNA icon

Means Investment Company’s Moderna MRNA Stock Holding History

Means Investment Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,702
Closed -$207K – 196
2023
Q2 		$207K Sell
1,702
-530
-24% -$70.7K 0.03% 193
2023
Q1 		$343K Buy
2,232
+101
+5% +$16.7K 0.06% 144
2022
Q4 		$383K Sell
2,131
-135
-6% -$22.1K 0.08% 136
2022
Q3 		$268K Sell
2,266
-40
-2% -$6.07K 0.06% 159
2022
Q2 		$329K Sell
2,306
-174
-7% -$24.9K 0.07% 140
2022
Q1 		$427K Sell
2,480
-189
-7% -$31.8K 0.08% 126
2021
Q4 		$678K Buy
2,669
+349
+15% +$102K 0.12% 99
2021
Q3 		$893K Buy
2,320
+396
+21% +$146K 0.18% 85
2021
Q2 		$452K Buy
1,924
+27
+1% +$4.83K 0.09% 121
2021
Q1 		$248K Buy
1,897
+31
+2% +$4.49K 0.06% 154
2020
Q4 		$342K Buy
+1,866
New +$189K 0.08% 135

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Means Investment Company's MRNA Position: Q3 2023 in Review

Means Investment Company sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,702 shares — an estimated $207K sold.

Means Investment Company first reported a position in MRNA in Q4 2020 and held it in 11 quarters. The position peaked at $893K in Q3 2021. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Means Investment Company reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Means Investment Company sold 1,702 Moderna shares in Q3 2023, an estimated $207K.
  • Means Investment Company first reported a position in Moderna in Q4 2020 and held it in 11 quarters.
  • Means Investment Company's Moderna position peaked at $893K in Q3 2021.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Means Investment Company's 13F filing for Q3 2023, filed 25 Oct 2023.